FI954657A0 - Biologisesti aktiivisia polypeptidifuusiodimeereja - Google Patents

Biologisesti aktiivisia polypeptidifuusiodimeereja

Info

Publication number
FI954657A0
FI954657A0 FI954657A FI954657A FI954657A0 FI 954657 A0 FI954657 A0 FI 954657A0 FI 954657 A FI954657 A FI 954657A FI 954657 A FI954657 A FI 954657A FI 954657 A0 FI954657 A0 FI 954657A0
Authority
FI
Finland
Prior art keywords
biologically active
active polypeptide
polypeptide fusion
dimers
fusion dimers
Prior art date
Application number
FI954657A
Other languages
English (en)
Swedish (sv)
Other versions
FI954657A (fi
Inventor
Arlen R Thomason
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of FI954657A0 publication Critical patent/FI954657A0/fi
Publication of FI954657A publication Critical patent/FI954657A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI954657A 1993-04-01 1995-09-29 Biologisesti aktiivisia polypeptidifuusiodimeereja FI954657A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4163593A 1993-04-01 1993-04-01
PCT/US1994/003581 WO1994022916A1 (en) 1993-04-01 1994-03-31 Biologically active polypeptide fusion dimers

Publications (2)

Publication Number Publication Date
FI954657A0 true FI954657A0 (fi) 1995-09-29
FI954657A FI954657A (fi) 1995-10-23

Family

ID=21917547

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954657A FI954657A (fi) 1993-04-01 1995-09-29 Biologisesti aktiivisia polypeptidifuusiodimeereja

Country Status (10)

Country Link
US (1) US5705484A (fi)
EP (2) EP0618227A1 (fi)
JP (1) JPH08503858A (fi)
AU (1) AU6497294A (fi)
CA (1) CA2159499A1 (fi)
FI (1) FI954657A (fi)
IL (1) IL109187A0 (fi)
NO (1) NO953882L (fi)
WO (1) WO1994022916A1 (fi)
ZA (1) ZA942206B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238890B1 (en) * 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
MX9601320A (es) * 1994-08-12 1997-05-31 Univ Washington Formas de cadena unica de cuarteto de hormona de glicoproteina.
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
US5994104A (en) * 1996-11-08 1999-11-30 Royal Free Hospital School Of Medicine Interleukin-12 fusion protein
US6165476A (en) * 1997-07-10 2000-12-26 Beth Israel Deaconess Medical Center Fusion proteins with an immunoglobulin hinge region linker
US6187564B1 (en) 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
US6242570B1 (en) 1997-07-10 2001-06-05 Beth Israel Deaconess Medical Center Production and use of recombinant protein multimers with increased biological activity
US6635256B1 (en) * 1998-10-19 2003-10-21 Washington University Glycoprotein hormone compositions comprising two β subunits and methods of use thereof
US6103501A (en) * 1997-11-17 2000-08-15 Washington University Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
US20060263382A1 (en) * 1998-06-20 2006-11-23 Richard Hotchkiss Membrane-permeant peptide complexes for treatment of sepsis
US8038984B2 (en) 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
JP2002529081A (ja) * 1998-11-06 2002-09-10 プレジデント アンド フェローズ オブ ハーバード カレッジ 生物学的事象のｆｋ５０６に基づく調節
US7109317B1 (en) 1998-11-06 2006-09-19 President And Fellows Of Harvard College FK506-based regulation of biological events
AU7546600A (en) * 1999-10-08 2001-04-23 Biofocus Discovery Limited Methods and compositions for targeting a cell
WO2003068802A2 (en) * 2002-02-11 2003-08-21 Zymogenetics, Inc. Materials and methods for preparing dimeric growth factors
CN103717614A (zh) 2011-08-09 2014-04-09 普罗法尔马封闭式股份公司 重组蛋白质的衍生物、粒细胞集落刺激因子的同多聚体及其制备方法
EP2854834A4 (en) 2012-05-30 2016-05-18 Biostrategies LC PLANT LECTINES AS AN EXCIPIENT OF RELATED MEDICINAL SUBSTANCES IN ANIMAL AND HUMAN CELLS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
EP0259632B1 (en) * 1986-08-13 1995-12-13 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0325224B1 (en) * 1988-01-22 1996-07-31 ZymoGenetics, Inc. Methods of producing secreted receptor analogs

Also Published As

Publication number Publication date
IL109187A0 (en) 1994-06-24
EP0691989A1 (en) 1996-01-17
NO953882L (no) 1995-11-28
ZA942206B (en) 1994-10-31
WO1994022916A1 (en) 1994-10-13
US5705484A (en) 1998-01-06
CA2159499A1 (en) 1994-10-13
FI954657A (fi) 1995-10-23
JPH08503858A (ja) 1996-04-30
EP0618227A1 (en) 1994-10-05
NO953882D0 (no) 1995-09-29
AU6497294A (en) 1994-10-24

Similar Documents

Publication Publication Date Title
NO953882D0 (no) Biologisk aktive polypeptidfusjonsdimerer
DK91192D0 (da) Protein
DE69410226T2 (de) Aktives Handsteuerungssystem
DE69425058D1 (de) Aktive kurzsteuerknüppel mit mechanischer verbindung
DE69411280T2 (de) Laser sintern mit mehreren strahlen
IL89804A0 (en) Biologically active proteins
GB9112553D0 (en) Fusion proteins
DE69416969T2 (de) Aktives Handsteuerungsystem
FI945085A (fi) Yhdistelmä-neu-reseptoristimulaatiotekijä
DK162890D0 (da) Polypeptid
IT1269630B (it) Giunto omocinetico fisso
DE59401126D1 (de) Aktives Stellelement
NO932148D0 (no) Fusjonspolypeptider
LV10962A (lv) Jauni peptidi
FI932780A (fi) Hitsausmenetelmä
DK132892D0 (da) Proteiner
NO980566D0 (no) Allergen-XCD32 fusjonsproteiner
FI940109A (fi) Peptidejä
DE69329145D1 (de) Anti-virale Fusionspeptide
BR9306576A (pt) Xilanase recombinante
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
FI945994A0 (fi) Rekombinoitu sellulaasi
DK284489D0 (da) Fusionsproteiner
NO932237L (no) Lineaere peptider
GB9321469D0 (en) Insecticidal proteins

Legal Events

Date Code Title Description
FD Application lapsed